Tp-e interval and Tp-e/QTc ratio: new choices for risk stratification of arrhythmic events in patients with hypertrophic cardiomyopathy ( Author`s Reply )

Kaynakça (6)

1. Akboğa MK, Gülcihan Balcı K, Yılmaz S, Aydın S, Yayla Ç, Ertem AG, et al. Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. Anatol J Cardiol 2017 Mar 9. Epub ahead of print
2. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-79
3. O\'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al; Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014; 35: 2010-20
4. Kang KW, Janardhan AH, Jung KT, Lee HS, Lee MH, Hwang HJ. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy. Heart Rhythm 2014; 11: 1433-40
5. Erikssen G, Liestol K, Gullestad L, Haugaa KH, Bendz B, Amlie JP. The terminal part of the QT interval (T peak to T end): A predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol 2012; 17: 85-94
6. Akboğa MK, Yüksel M, Balcı KG, Kaplan M, Cay S, Gökbulut V, et al. Tp-e interval, Tp-e/QTc ratio, and fragmented QRS are correlated with the severity of liver cirrhosis. Ann Noninvasive Electrocardiol 2017; 22: e12359.